うっ血性心不全(CHF)治療装置の世界市場分析:製品別(心室補助装置、カウンター脈動装置、植込み型除細動器、心臓ペースメーカー、心臓再同期療法)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Congestive Heart Failure (CHF) Treatment Devices Market Analysis by Product (Ventricular Assist Devices, Counter Pulsation Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization Therapy) And Segment Forecasts to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends& Scope
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Rising prevalence of cardiovascular diseases (CVD)
4.1.1.2 Favorable reimbursement policies
4.1.1.3 Advent of technological advanced products
4.1.1.4 Growing geriatric population base
4.1.2 Market Restraint Analysis
4.1.2.1 Stringent regulation and approval
4.1.2.2 High cost of devices
4.2 CHF treatment devices market: Company market share, 2015
4.3 Penetration & growth prospect mapping
4.4 CHF Treatment Devices – SWOT Analysis, By Factor (political & legal, economic and technological)
4.5 Industry Analysis – Porter’s
Chapter 5 Market Categorization : Product Estimates & Trend Analysis
5.1 Congestive Heart Failure Treatment Devices Market: Product movement analysis
5.2 Ventricular assist devices (VAD)
5.2.1 Ventricular assist devices market, 2013 – 2024 (USD Million)
5.2.2 Left Ventricular Assist Devices (LVAD)
5.2.2.1 Left Ventricular Assist Devices market, 2013 – 2024 (USD Million)
5.2.3 Right Ventricular Assist Devices (RVAD)
5.2.3.1 Right Ventricular Assist Devices market, 2013 – 2024 (USD Million)
5.2.4 Biventricular Assist Devices (BIVAD)
5.2.4.1 Biventricular Assist Devices market, 2013 – 2024 (USD Million)
5.3 Counter Pulsation Devices
5.3.1 Counter pulsation devices market, 2013 – 2024 (USD Million)
5.4 Implantable Cardioverter Defibrillators (ICD)
5.4.1 Implantable cardioverter defibrillators market, 2013 – 2024 (USD Million)
5.4.2 Transvenous ICDs
5.4.2.1 Transvenous ICDs market, 2013 – 2024 (USD Million)
5.4.3 Subcutaneous ICDs
5.4.3.1 Subcutaneous ICDs market, 2013 – 2024 (USD Million)
5.5 Pacemakers
5.5.1 Pacemakers market, 2013 – 2024 (USD Million)
5.5.2 Implantable pacemakers
5.5.2.1 Implantable pacemakers market, 2013 – 2024 (USD Million)
5.5.3 External pacemakers
5.5.3.1 External pacemakers market, 2013 – 2024 (USD Million)
5.6 Cardiac Resynchronization Therapy (CRT)
5.6.1 Cardiac resynchronization therapy market, 2013 – 2024 (USD Million)
5.6.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-D)
5.6.2.1 CRT-D market, 2013 – 2024 (USD Million)
5.6.3 Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
5.6.3.1 CRT-P market, 2013 – 2024 (USD Million)
Chapter 6 Market Categorization: Regional Estimates & Trend Analysis, by Product
6.1 Congestive heart failure treatment devices market share by region, 2015 & 2024
6.2 North America
6.2.1 North America CHF treatment devices market, 2013 – 2024 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. CHF treatment devices market, 2013 – 2024 (USD Million)
6.2.3 Canada
6.2.3.1 Canada CHF treatment devices market, 2013 – 2024 (USD Million)
6.3 Europe
6.3.1 Europe CHF treatment devices market, 2013 – 2024 (USD Million)
6.3.2 UK
6.3.2.1 UK CHF treatment devices market, 2013 – 2024 (USD Million)
6.3.3 Germany
6.3.4 Germany CHF treatment devices market, 2013 – 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific CHF treatment devices market, 2013 – 2024 (USD Million)
6.4.2 Japan
6.4.2.1 Japan CHF treatment devices market, 2013 – 2024 (USD Million)
6.4.3 China
6.4.3.1 China CHF treatment devices market, 2013 – 2024 (USD Million)
6.5 Latin America
6.5.1 Latin America CHF treatment devices market, 2013 – 2024 (USD Million)
6.5.2 Brazil
6.5.3 Brazil CHF treatment devices market, 2013 – 2024 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico CHF treatment devices market, 2013 – 2024 (USD Million)
6.6 MEA
6.6.1 MEA CHF treatment devices market, 2013 – 2024 (USD Million)
6.6.2 South Africa
6.6.3 South Africa ca CHF treatment devices market, 2013 – 2024 (USD Million)
6.7 Saudi Arabia
6.7.1 Saudi Arabia CHF treatment devices market, 2013 – 2024 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participant categorization
7.2.1 Jarvik Heart Inc.
7.2.1.1 Company Overview
7.2.1.2 Financial Performance
7.2.1.3 Product Benchmarking
7.2.1.4 Strategic initiatives
7.2.2 ReliantHeart, Inc.
7.2.2.1 Company Overview
7.2.2.2 Financial Performance
7.2.2.3 Product Benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Biotronik SE & Co., KG
7.2.3.1 Company Overview
7.2.3.2 Financial Performance
7.2.3.3 Product Benchmarking
7.2.3.4 Strategic Initiatives
7.2.3.5 Additional Information
7.2.4 Berlin Heart GmbH
7.2.4.1 Company Overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.5 St. Jude Medical, Inc.
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Product Benchmarking
7.2.5.4 Financial Performance
7.2.6 Medtronic
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Product Benchmarking
7.2.6.4 Strategic Initiatives
7.2.7 Boston Scientific Corporation
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3 Product Benchmarking
7.2.7.4 Strategic Initiatives
7.2.8 Teleflex, Inc.
7.2.8.1 Company Overview
7.2.8.2 Financial Performance
7.2.8.3 Product Benchmarking
7.2.8.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:うっ血性心不全(CHF)治療装置の世界市場分析:製品別(心室補助装置、カウンター脈動装置、植込み型除細動器、心臓ペースメーカー、心臓再同期療法)、セグメント予測
■ 英文:Congestive Heart Failure (CHF) Treatment Devices Market Analysis by Product (Ventricular Assist Devices, Counter Pulsation Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization Therapy) And Segment Forecasts to 2024
■ 発行日:2016年10月15日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707213
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。